lung-cancer

Documents about lung-cancer

• Metformin in Non Small Cell Lung Cancer (NSCLC)#18575ClinicalTrials.gov
• Adaptive Symptom Self-Management Immunotherapy Study#18578ClinicalTrials.gov
• Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)#18627ClinicalTrials.gov
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer#28305ClinicalTrials.gov
• Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study#28477ClinicalTrials.gov
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893ClinicalTrials.gov
• Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers#121340ClinicalTrials.gov
• Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer#123479ClinicalTrials.gov
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors#123552ClinicalTrials.gov
• Brodalumab in the Treatment of Immune-Related Adverse Events#346915ClinicalTrials.gov
• irAE Prediction of Anti-PD-1/L1 in Lung Cancer#346927ClinicalTrials.gov
• HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer#346976ClinicalTrials.gov
• D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)#349957ClinicalTrials.gov
• Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer#349972ClinicalTrials.gov
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas#353265ClinicalTrials.gov
• Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer#356465ClinicalTrials.gov
• Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers#366602ClinicalTrials.gov
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer#366603ClinicalTrials.gov
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer#366616ClinicalTrials.gov
• Sex ratio disparities in the two most common cancers worldwide: an exploratory analysis using GLOBOCAN 2022 data, gender inequalities, and economic indicators#13218HAL (France)
• The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy#280409HAL (France)

Related topics